Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikinkaari 9B, FI-00014 Helsinki, Finland.
Postnova Analytics, Max-Planck-Str. 14, 86899 Landsberg, Germany.
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Sep 15;1095:251-257. doi: 10.1016/j.jchromb.2018.07.008. Epub 2018 Jul 10.
Basic and applied virus research requires specimens that are purified to high homogeneity. Thus, there is much interest in the efficient production and purification of viruses and their subassemblies. Advances in the production steps have shifted the bottle neck of the process to the purification. Nonetheless, the development of purification techniques for different viruses is challenging due to the complex biological nature of the infected cell cultures as well as the biophysical and -chemical differences in the virus particles. We used bacteriophage ϕ6 as a model virus in our attempts to provide a new purification method for enveloped viruses. We compared asymmetrical flow field-flow fractionation (AF4)-based virus purification method to the well-established ultracentrifugation-based purification of ϕ6. In addition, binding of ϕ6 virions to monolithic anion exchange columns was tested to evaluate their applicability in concentrating the AF4 purified specimens. Our results show that AF4 enables one-hour purification of infectious enveloped viruses with specific infectivity of ~1 × 10 PFU/mg of protein and ~65-95% yields. Obtained purity was comparable with that obtained using ultracentrifugation, but the yields from AF4 purification were 2-3-fold higher. Importantly, high quality virus preparations could be obtained directly from crude cell lysates. Furthermore, when used in combination with in-line light scattering detectors, AF4 purification could be coupled to simultaneous quality control of obtained virus specimen.
基础和应用病毒研究需要高度均一的纯化标本。因此,人们对高效生产和纯化病毒及其亚单位非常感兴趣。生产步骤的进步将该过程的瓶颈转移到了纯化步骤。然而,由于受感染细胞培养物的复杂生物学性质以及病毒颗粒的生物物理和化学差异,针对不同病毒开发纯化技术具有挑战性。我们使用噬菌体ϕ6作为模型病毒,试图为包膜病毒提供一种新的纯化方法。我们将基于不对称流场流分离(AF4)的病毒纯化方法与基于超速离心的ϕ6 纯化方法进行了比较。此外,还测试了ϕ6 病毒粒子与整体式阴离子交换柱的结合,以评估它们在浓缩 AF4 纯化标本中的适用性。我们的结果表明,AF4 能够在一小时内纯化具有约 1×10 PFU/mg 蛋白的感染性包膜病毒,且收率约为 65-95%。获得的纯度与超速离心获得的纯度相当,但 AF4 纯化的收率要高出 2-3 倍。重要的是,可以直接从粗细胞裂解物中获得高质量的病毒制剂。此外,当与在线光散射检测器结合使用时,AF4 纯化可以与获得的病毒标本的同时质量控制相结合。